Delivery Order SPE2DB22D3016-SPE2DB25FAJV0

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1106 and SPE2DB24FEMH3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,239.02 firm-fixed-price delivery order is for the supply of 4,564,325,579 units of Depakote ER 250 mg tablets. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,582.08 firm fixed-price delivery order is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a medication used for various medical conditions. The contract has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.29 firm fixed-price contract is for the delivery of Depakote DR 125 mg medication sprinkle capsules. It is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC1G9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Depakote ER 250 mg tablets, a medication used to treat certain types of seizures. The contract has a firm fixed price, with a ceiling value of $2,912.28, and an ultimate completion date of May 6, 2025. This...
This federal contract award, valued at $1,575.84, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on May 9, 2024. The contract is for the provision of Depakote DR 125 mg sprinkle capsules to DLA facilities supporting the Department of Defense (DoD) worldwide. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that allows the agency to...
This federal contract award is for the delivery of 4,558,950,443 units of Depakote ER 250 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,594.68, was issued to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of November 2, 2022 and was awarded on November 1, 2022 with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FT8H7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.84 delivery order is for the supply of 4560222536 DEPAKOTE DR 125 MG SPRINKLE CP 100S, a pharmaceutical product. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,559,459 units of Depakote DR 125 mg sprinkle capsules. The $2,097.41 firm fixed-price contract was awarded on December 27, 2022 by the Defense Logistics Agency (DLA), with a completion date of December 28, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,290.00 Firm Fixed Price delivery order provides for the supply of DIVALPROEX SOD ER 500 MG TAB 100S, a prescription medication. The contract has an ultimate completion date of September 13, 2022 and was awarded on September 12, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAJV0
    Delivery Order

This contract award, SPE2DB22D3016|SPE2DB25FAJV0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,579.83 firm fixed-price delivery order is for the supply of 100 units of DEPAKOTE ER 250 MG TABLET, a medication used for various medical conditions. The award is not set aside for any specific business type.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/11/25, 11:12 AM